Cargando…
The correlation between probiotic use and outcomes of cancer patients treated with immune checkpoint inhibitors
Objective: Immune checkpoint inhibitors (ICIs) have recently demonstrated promising results in improving the prognosis of cancer patients. The goal of this meta-analysis was to determine the impact of probiotic use on the survival of cancer patients treated with ICIs. Methods: Before 3 March 2022, t...
Autores principales: | Zhang, Lilong, Jin, Qi, Chai, Dongqi, Kuang, Tianrui, Li, Chunlei, Guan, Yongjun, Liu, Li, Wang, Weixing, Deng, Wenhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468893/ https://www.ncbi.nlm.nih.gov/pubmed/36110546 http://dx.doi.org/10.3389/fphar.2022.937874 |
Ejemplares similares
-
The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
por: Zhang, Lilong, et al.
Publicado: (2022) -
Effects of PPIs use on clinical outcomes of urothelial cancer patients receiving immune checkpoint inhibitor therapy
por: Zhang, Lilong, et al.
Publicado: (2022) -
Low geriatric nutritional risk index as a poor prognostic biomarker for immune checkpoint inhibitor treatment in solid cancer
por: Zhang, Lilong, et al.
Publicado: (2023) -
Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma
por: Zhang, Lilong, et al.
Publicado: (2023) -
Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma
por: Zhang, Lilong, et al.
Publicado: (2023)